Literature DB >> 33679783

Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression.

Wenxiao Jia1, Hui Zhu2, Qianqian Gao3, Jian Sun4, Fujian Tan5, Qun Liu5, Hongbo Guo1,4, Jinming Yu1,2.   

Abstract

A 56-year-old male was diagnosed with right lung upper lobe squamous cancer with right hilar and mediastinum lymph node metastasis. After four cycles of neoadjuvant immunochemotherapy, reexamination by computed tomography showed progressive disease of the primary lesion. Then, the patient underwent a right lung upper lobectomy, and hilar and mediastinum lymph node dissection. Surgical pathology showed a partial response to immunochemotherapy. Single-cell RNA sequencing was used to characterize the infiltrating immune cell atlas after neoadjuvant immunochemotherapy; the most common infiltrating immune cell types were cytotoxic CD8+ T cells, monocyte-derived dendritic cells, and macrophages. Imaging mass cytometry revealed a transformation from cold to hot tumor after neoadjuvant immunochemotherapy. In this case study, we are the first to report a case of neoadjuvant immunochemotherapy pseudoprogression, proved by surgical pathology, single-cell RNA sequencing, and imaging mass cytometry. Both single-cell RNA sequencing and imaging mass cytometry revealed an activated immune microenvironment after neoadjuvant immunochemotherapy.
Copyright © 2021 Jia, Zhu, Gao, Sun, Tan, Liu, Guo and Yu.

Entities:  

Keywords:  NSCLC; imaging mass cytometry; immunotherapy; pseudoprogression; single-cell RNA-sequencing

Year:  2021        PMID: 33679783      PMCID: PMC7925896          DOI: 10.3389/fimmu.2021.633534

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  31 in total

1.  Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

Authors:  Patrick M Forde; Jamie E Chaft; Kellie N Smith; Valsamo Anagnostou; Tricia R Cottrell; Matthew D Hellmann; Marianna Zahurak; Stephen C Yang; David R Jones; Stephen Broderick; Richard J Battafarano; Moises J Velez; Natasha Rekhtman; Zachary Olah; Jarushka Naidoo; Kristen A Marrone; Franco Verde; Haidan Guo; Jiajia Zhang; Justina X Caushi; Hok Yee Chan; John-William Sidhom; Robert B Scharpf; James White; Edward Gabrielson; Hao Wang; Gary L Rosner; Valerie Rusch; Jedd D Wolchok; Taha Merghoub; Janis M Taube; Victor E Velculescu; Suzanne L Topalian; Julie R Brahmer; Drew M Pardoll
Journal:  N Engl J Med       Date:  2018-04-16       Impact factor: 91.245

2.  CD103+CD8+ Lymphocytes Characterize the Immune Infiltration in a Case With Pseudoprogression in Squamous NSCLC.

Authors:  Pedro Rocha; Max Hardy-Werbin; Dolores Naranjo; Álvaro Taus; Maite Rodrigo; Flavio Zuccarino; René Roth; Oliver Wood; Christian H Ottensmeier; Edurne Arriola
Journal:  J Thorac Oncol       Date:  2018-07-19       Impact factor: 15.609

3.  Pseudoprogression: A case of metastatic renal clear cell carcinoma treated with nivolumab.

Authors:  Tadashi Tabei; Yukio Tsuura; Kazuki Kobayashi
Journal:  Pathol Int       Date:  2018-08-27       Impact factor: 2.534

Review 4.  Dendritic cells in cancer immunology and immunotherapy.

Authors:  Stefanie K Wculek; Francisco J Cueto; Adriana M Mujal; Ignacio Melero; Matthew F Krummel; David Sancho
Journal:  Nat Rev Immunol       Date:  2019-08-29       Impact factor: 53.106

Review 5.  Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease.

Authors:  Qiang Zhang; Brian T Helfand; Benedito A Carneiro; Weijun Qin; Ximing J Yang; Chung Lee; Weipeng Zhang; Francis J Giles; Massimo Cristofanilli; Timothy M Kuzel
Journal:  Eur Urol       Date:  2017-12-21       Impact factor: 20.096

Review 6.  Antigen processing and presentation.

Authors:  Fiorella Kotsias; Ignacio Cebrian; Andrés Alloatti
Journal:  Int Rev Cell Mol Biol       Date:  2019-08-01       Impact factor: 6.813

Review 7.  Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.

Authors:  Kathryn C Arbour; Gregory J Riely
Journal:  JAMA       Date:  2019-08-27       Impact factor: 56.272

Review 8.  Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.

Authors:  Jinfang Zhang; Fabin Dang; Junming Ren; Wenyi Wei
Journal:  Trends Biochem Sci       Date:  2018-10-01       Impact factor: 13.807

Review 9.  Immune checkpoint inhibitors of PD-L1 as cancer therapeutics.

Authors:  Akintunde Akinleye; Zoaib Rasool
Journal:  J Hematol Oncol       Date:  2019-09-05       Impact factor: 17.388

10.  The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy.

Authors:  Wenxiao Jia; Qianqian Gao; Anqin Han; Hui Zhu; Jinming Yu
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

View more
  1 in total

1.  Integrative Characterization of the Role of IL27 In Melanoma Using Bioinformatics Analysis.

Authors:  Chunyu Dong; Dan Dang; Xuesong Zhao; Yuanyuan Wang; Zhijun Wang; Chuan Zhang
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.